Related Experiment Video

Updated: Jul 6, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

Micafungin for the prophylaxis and treatment of Candida infections

Joseph M Fritz1, Benjamin D Brielmaier, Erik R Dubberke

  • 1Washington University School of Medicine, Division of Infectious Diseases, Department of Internal Medicine, 660 South Euclid Avenue, Campus Box 8051, St Louis, MO 63110, USA. jfritz@im.wustl.edu

Expert Review of Anti-Infective Therapy
|April 3, 2008
PubMed

Insights

Micafungin, an echinocandin antifungal, offers potent activity against invasive fungal infections with reduced toxicity. It is approved for esophageal candidiasis, prophylaxis in stem cell transplant patients, and invasive candidiasis treatment.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Invasive fungal infections (IFIs) pose a significant global health burden, marked by increasing incidence and antifungal resistance.
  • The emergence of drug-resistant fungal strains necessitates the development of novel and effective antifungal therapies.
  • Echinocandins represent a crucial class of antifungals with a unique mechanism of action, offering a favorable safety profile.

Purpose of the Study:

  • To review the clinical applications and therapeutic profile of micafungin, an echinocandin antifungal agent.
  • To highlight micafungin's efficacy in treating various invasive Candida infections and its role in prophylaxis.
  • To discuss the safety and drug-interaction profile of micafungin in clinical practice.

Main Methods:

  • Review of clinical trial data and published literature on micafungin.
  • Analysis of micafungin's mechanism of action, spectrum of activity, and pharmacokinetic properties.
  • Evaluation of safety, tolerability, and drug-interaction data from clinical studies.

Main Results:

  • Micafungin demonstrates potent activity against Candida species, including some resistant strains.
  • Approved indications include treatment of esophageal candidiasis and invasive candidiasis (candidemia, etc.) in adults.
  • It is the only echinocandin approved for prophylaxis of Candida infection in hematopoietic stem cell transplant recipients.
  • Micafungin exhibits a favorable safety profile with generally low toxicity and minimal drug interactions.

Conclusions:

  • Micafungin is a valuable therapeutic option for invasive fungal infections caused by Candida species.
  • Its unique mechanism, broad spectrum of activity, and favorable safety profile enhance its clinical utility.
  • Micafungin plays a significant role in both treatment and prophylaxis of invasive candidiasis, particularly in immunocompromised patients.

More Related Videos

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms07:19

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms

Published on: October 21, 2010

Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening08:05

Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening

Published on: July 18, 2012

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...